XTalks
MARCH 7, 2024
Experts discuss the therapeutic landscape, treatment gaps, regulatory considerations and clinical trial strategies. The webinar provides insights into a novel method that facilitates detailed genetic analysis of breast cancer, marrying the depth of whole-genome studies with the precision of targeted analysis at the single-cell level.
Drug Discovery World
MARCH 2, 2023
AVA6000 is a pre|CISION tumour-targeted form of the established chemotherapy doxorubicin; designed to limit cell penetration of the drug — and therefore its cell killing effect — until it is specifically activated by fibroblast activation protein α (FAP), which is in high concentration in many solid tumours compared with healthy tissues.
Drug Discovery World
JUNE 14, 2023
It enables development and production of Advanced Therapies by providing access to human cells and tissue, testing services and biomanufacturing and clinical trials support.
Expert insights. Personalized for you.
115 
Let's personalize your content